Regular testing for oxidative stress improves health outcomes
the verdict
INSUFFICIENT LEANING
refutedsupported
the weight of evidence
3 sources for · 0 against
The retrieved evidence discusses oxidative stress biomarkers and their relevance to conditions like PCOS and mortality, but does not establish that regular testing for oxidative stress improves health outcomes.
Background/Objectives: Infertility in both men and women can be significantly influenced by oxidative stress (OS), which occurs due to an imbalance between reactive oxygen species (ROS) and the body’s antioxidant defenses. In women, OS disrupts oocyte maturation, implantation, and the viability of the embryo; in men, it impairs sperm quality, reduces motility, and damages DNA integrity. This review explores existing research on how dietary and lifestyle interventions can reduce OS and enhance reproductive health outcomes. Methods: We conducted a comprehensive review of clinical, translational, and molecular studies exploring the mechanisms by which OS affects fertility, as well as the efficacy of nutritional and behavioral strategies. The interventions evaluated include weight management, regular exercise, micronutrient supplementation, antioxidant-rich diets, smoking and alcohol cessation, and stress-reduction techniques. Results: Specific dietary components such as zinc, selenium, vitamins C and E, and polyphenols have been found to neutralize reactive oxygen species (ROS) and enhance gamete function. OS is additionally reduced through lifestyle modifications, including minimizing harmful exposures, managing stress, and participating in moderate physical activity. Biomarkers such as ROS levels, total antioxidant capacity, 8-OHdG, and DNA fragmentation index are essential for assessing the effectiveness of interventions. Conclusions: Fertility in both sexes can be improved, and oxidative stress significantly reduced, through a multimodal approach incorporating dietary and lifestyle changes. There are encouraging opportunities to improve reproductive health through customized approaches that are informed by biomarker profiles. To incorporate these treatments into regular fertility care, future studies should concentrate on standardized procedures and long-term results.
Polycystic ovary syndrome (PCOS) is a common endocrine metabolic disorder characterized by hyperandrogenism, ovulatory dysfunction, and insulin resistance. Increasing evidence suggests that oxidative stress (OS) contributes to its metabolic and reproductive complications. Objectives: To systematically review primary studies evaluating oxidative stress biomarkers in PCOS and their associations with metabolic outcomes. Methods: A comprehensive search was conducted in PubMed, Scopus, and Cochrane Library up to April 2024, following PRISMA 2020 guidelines. Eligible studies included case–control and cross-sectional designs reporting quantitative OS biomarker data in PCOS versus controls. Quality and risk of bias were assessed using the Newcastle Ottawa Scale (NOS). Results: Fifteen studies (2014–2024) involving over 1,000 participants were included. Malondialdehyde (MDA) was elevated in nearly all studies, indicating enhanced lipid peroxidation. Total antioxidant capacity (TAC/FRAP) and enzymatic antioxidants (SOD, CAT) were consistently reduced, while non-enzymatic antioxidants (GSH, vitamins A/C/E) were also lower. PON1 activity and sRAGE levels decreased, and 8-isoprostane in follicular fluid correlated with poorer oocyte quality. OS markers were positively associated with BMI, insulin resistance, and dyslipidemia. Five studies were rated low risk and ten moderate risk by NOS criteria. Conclusions: PCOS is characterized by increased oxidative stress and reduced antioxidant defense, closely linked to metabolic severity. Incorporating OS biomarkers into clinical evaluation and exploring phenotype-specific antioxidant interventions may improve metabolic and reproductive outcomes. Future longitudinal studies should standardize biomarker measurement to strengthen clinical applicability.
The impact of oxidative balance on all-cause and cause-specific mortality in US adults and cancer survivors: evidence from NHANES 2001–2018 | BMC Cancer | Springer Nature Link
# The impact of oxidative balance on all-cause and cause-specific mortality in US adults and cancer survivors: evidence from NHANES 2001–2018
- Research
- Open access
- Published: 23 January 2025
- Volume 25, article number 133 (2025)
- Cite this article
You have full access to this open access article
BMC Cancer Aims and scope Submit manuscript
## Abstract
### Background
Oxidative stress is a crucial pathophysiological mechanism in chronic diseases and mortality. While individual oxidative markers have been studied, the comprehensive impact of oxidative balance on mortality risks remains unclear, particularly among cancer survivors. We aimed to investigate the associations of Oxidative Balance Score (OBS) with mortality in both the general population and cancer survivors.
### Methods
This study included 37,317 adults (52% female) from the National Health and Nutrition Examination Survey (2001–2018). OBS was calculated based on antioxidant and pro-oxidant exposures and categorized into quartiles. Su
Everything we examined (3)
This check searched the claim as stated. It did not run a separate search for evidence against it.